You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/74892
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAlves, Ana Liz Garcia-
dc.contributor.authorde Mattos Carvalho, Armando-
dc.contributor.authorHussni, Carlos Alberto-
dc.date.accessioned2014-05-27T11:28:44Z-
dc.date.accessioned2016-10-25T18:45:55Z-
dc.date.available2014-05-27T11:28:44Z-
dc.date.available2016-10-25T18:45:55Z-
dc.date.issued2013-03-28-
dc.identifierhttp://dx.doi.org/10.2174/2210296511303020002-
dc.identifier.citationRecent Patents on Regenerative Medicine, v. 3, n. 2, p. 103-110, 2013.-
dc.identifier.issn2210-2965-
dc.identifier.issn2210-2973-
dc.identifier.urihttp://hdl.handle.net/11449/74892-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/74892-
dc.description.abstractTendinitis is an important disease that leads to lameness and decreased performance in equine athletes and results in high costs associated with therapy due to a long recovery period and a high rate of recurrence. Although, several treatments for equine tendinitis have been described, few are effective in significantly improving the quality of the extracellular matrix and reducing the rate of recurrence. The use of cell therapy with mesenchymal stem cells (MSCs) derived from various sources has received much attention because of its therapeutic potential for equine tendinitis. In this paper, we review patents on stem cell therapy and the specific use of MSCs for the treatment of equine tendinitis. © 2013 Bentham Science Publishers.en
dc.format.extent103-110-
dc.language.isoeng-
dc.sourceScopus-
dc.subjectAdipose tissue-
dc.subjectAdult stem cells-
dc.subjectBone marrow-
dc.subjectCell therapy-
dc.subjectEquine-
dc.subjectTendinitis-
dc.subject5' nucleotidase-
dc.subjectbone morphogenetic protein 12-
dc.subjectcell marker-
dc.subjectendoglin-
dc.subjectscatter factor-
dc.subjectsomatomedin C-
dc.subjectThy 1 antigen-
dc.subjectvasculotropin-
dc.subjectapoptosis-
dc.subjectbone marrow biopsy-
dc.subjectcell adhesion-
dc.subjectcell proliferation-
dc.subjectcell transdifferentiation-
dc.subjectextracellular matrix-
dc.subjectgene expression-
dc.subjecthematopoietic stem cell-
dc.subjecthistopathology-
dc.subjecthorse-
dc.subjecthuman-
dc.subjectimmunophenotyping-
dc.subjectmesenchymal stem cell transplantation-
dc.subjectmultipotent stem cell-
dc.subjectnonhuman-
dc.subjectpriority journal-
dc.subjectrecurrence risk-
dc.subjectreview-
dc.subjectsarcoma-
dc.subjecttendinitis-
dc.subjecttissue engineering-
dc.subjectwound healing-
dc.titleMesenchymal stem cell therapy for equine tendinitisen
dc.typeoutro-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.description.affiliationDepartment of Veterinary Surgery and Anesthesiology School of Veterinary Medicine and Animal Science São Paulo State University (UNESP), Rubião Juniors. número, Botucatu, SP-
dc.description.affiliationUnespDepartment of Veterinary Surgery and Anesthesiology School of Veterinary Medicine and Animal Science São Paulo State University (UNESP), Rubião Juniors. número, Botucatu, SP-
dc.identifier.doi10.2174/2210296511303020002-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofRecent Patents on Regenerative Medicine-
dc.identifier.scopus2-s2.0-84875317890-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
Show simple item record Show full item record   View Statistics
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.